Inspire Medical Systems
INSP
357 hedge funds and large institutions have $6.2B invested in Inspire Medical Systems in 2024 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 119 increasing their positions, 127 reducing their positions, and 44 closing their positions.
36% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 44
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
3% more funds holding
Funds holding: 346 → 357 (+11)
0.26% less ownership
Funds ownership: 111.75% → 111.49% (-0.26%)
6% less repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 127
12% less capital invested
Capital invested by funds: $7.03B → $6.2B (-$826M)
26% less call options, than puts
Call options by funds: $54.8M | Put options by funds: $73.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
Dragoneer Investment Group
San Francisco,
California
|
+$169M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
+$84.2M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$59.9M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$50.9M |
| 5 |
Morgan Stanley
New York
|
+$43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$223M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$83.1M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$67.4M |
| 4 |
JP Morgan Chase
New York
|
-$43.2M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$42.8M |
INSP Hedge Fund Activity: Q4 2024 in Review
357 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q4 2024, worth a combined $6.2B — down 12% from $7.03B a quarter earlier.
Buyers outnumbered sellers: 60 funds opened new INSP positions and 44 closed out — a net gain of 16 holders — while 119 added to existing stakes and 127 trimmed.
The largest buyer was Dragoneer Investment Group, opening a new position worth an estimated $169M. The largest seller was Wellington Management Group, cutting an estimated $223M.
- 357 institutional investors held Inspire Medical Systems (INSP) as of Q4 2024, up from 346 in Q3 2024.
- Funds reported $6.2B of Inspire Medical Systems stock for Q4 2024, down 12% quarter-over-quarter.
- 60 funds opened new Inspire Medical Systems positions in Q4 2024 and 44 closed out, a net change of +16 holders.
- The largest Inspire Medical Systems buyer in Q4 2024 was Dragoneer Investment Group, an estimated $169M added.
- The largest Inspire Medical Systems seller in Q4 2024 was Wellington Management Group, an estimated $223M sold.
Based on aggregated 13F filings for Q4 2024.